Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Erectile Dysfunction
NCT04350125Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2022
- Primary completion
- Oct 2023
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous platelet-rich plasma in erectile dysfunction (ED), sponsored by Mayo Clinic. Primary endpoint: Treatment-related adverse events at 35 weeks. Started Mar 2022; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04350125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04350125.